| A new taxonomy for describing and defining adherence to medications B Vrijens, S De Geest, DA Hughes, K Przemyslaw, J Demonceau, ... British journal of clinical pharmacology 73 (5), 691-705, 2012 | 2144 | 2012 |
| Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic … J Demonceau, T Ruppar, P Kristanto, DA Hughes, E Fargher, P Kardas, ... Drugs 73, 545-562, 2013 | 386 | 2013 |
| Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research EAF Holmes, DA Hughes, VL Morrison Value in Health 17 (8), 863-876, 2014 | 228 | 2014 |
| Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription EA Fargher, K Tricker, W Newman, R Elliott, SA Roberts, JL Shaffer, ... Journal of clinical pharmacy and therapeutics 32 (2), 187-195, 2007 | 129 | 2007 |
| Patients’ and healthcare professionals’ views on pharmacogenetic testing and its future delivery in the NHS EA Fargher, C Eddy, W Newman, F Qasim, K Tricker, RA Elliott, K Payne Future Medicine Ltd 8 (11), 1511-1519, 2007 | 124 | 2007 |
| Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey VL Morrison, EAF Holmes, S Parveen, CO Plumpton, W Clyne, ... Value in Health 18 (2), 206-216, 2015 | 116 | 2015 |
| A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study WG Newman, K Payne, K Tricker, SA Roberts, E Fargher, S Pushpakom, ... Pharmacogenomics 12 (6), 815-826, 2011 | 90 | 2011 |
| Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences K Payne, EA Fargher, SA Roberts, K Tricker, RA Elliott, J Ratcliffe, ... Value in health 14 (1), 121-134, 2011 | 86 | 2011 |
| TPMT testing in rheumatology: any better than routine monitoring? K Payne, W Newman, E Fargher, K Tricker, IN Bruce, WER Ollier Rheumatology 46 (5), 727-729, 2007 | 58 | 2007 |
| Conducting economic evaluations alongside randomised trials: current methodological issues and novel approaches D Hughes, J Charles, D Dawoud, RT Edwards, E Holmes, C Jones, ... Pharmacoeconomics 34, 447-461, 2016 | 53 | 2016 |
| Cost-effectiveness analysis of the use of point-of-care C-reactive protein testing to reduce antibiotic prescribing in primary care EAF Holmes, SD Harris, A Hughes, N Craine, DA Hughes Antibiotics 7 (4), 106, 2018 | 49 | 2018 |
| Attitudes towards epilepsy in the UK population: results from a 2018 national survey E Holmes, S Bourke, C Plumpton Seizure 65, 12-19, 2019 | 41 | 2019 |
| Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery G Powell, EAF Holmes, CO Plumpton, A Ring, GA Baker, A Jacoby, ... British journal of clinical pharmacology 80 (5), 1149-1159, 2015 | 29 | 2015 |
| Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment ST Yeo, RT Edwards, EA Fargher, SD Luzio, RL Thomas, DR Owens Diabetic medicine 29 (7), 869-877, 2012 | 29 | 2012 |
| Patient‐Focused Drug Development Methods for Benefit–Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs EAF Holmes, C Plumpton, GA Baker, A Jacoby, A Ring, P Williamson, ... Clinical Pharmacology & Therapeutics 105 (3), 672-683, 2019 | 27 | 2019 |
| Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria F Lötsch, L Auer-Hackenberg, M Groger, K Rehman, V Morrison, ... Wiener klinische Wochenschrift 127, 379-384, 2015 | 26 | 2015 |
| Investigating preferences for support with life after stroke: a discrete choice experiment CR Burton, E Fargher, C Plumpton, GW Roberts, H Owen, E Roberts BMC health services research 14, 1-13, 2014 | 26 | 2014 |
| Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis? LM Davies, EA Fargher, K Tricker, P Dawes, DL Scott, D Symmons Annals of the rheumatic diseases 66 (5), 658-663, 2007 | 17 | 2007 |
| What influences persistence with medicines? A multinational discrete choice experiment of 2549 patients EAF Holmes, VL Morrison, DA Hughes British Journal of Clinical Pharmacology 82 (2), 522-531, 2016 | 16 | 2016 |
| TARGET study recruitment team. A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study WG Newman, K Payne, K Tricker, SA Roberts, E Fargher, S Pushpakom, ... Pharmacogenomics 12 (6), 815-826, 2011 | 14 | 2011 |
